Is IMGI or JNJ a better dividend investment in 2026?

IMGI currently yields 8333333.33% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: IMGI offers higher current income.

What is the dividend yield difference between IMGI and JNJ?

IMGI has a forward dividend yield of 8333333.33% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 8333331.20 percentage points.

Home › Compare › IMGI vs JNJ

IMGI vs JNJ: Dividend Comparison 2026

IMGI yields 8333333.33% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMGI wins by $7.691208561253763e+45M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMGI

● Live price

8333333.33%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7.691208561253763e+45M

Annual income

$7,691,027,008,283,142,000,000,000,000,000,000,000,000,000,000,000,000.00

Full IMGI calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — IMGI vs JNJ

📍 IMGI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMGI	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMGI + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMGI pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMGI

Annual income on $10K today (after 15% tax)

$708,333,333.33/yr

After 10yr DRIP, annual income (after tax)

$6,537,372,957,040,671,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, IMGI beats the other by $6,537,372,957,040,671,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMGI + JNJ for your $10,000?

IMGI: 50%JNJ: 50%

100% JNJ50/50100% IMGI

Portfolio after 10yr

$3.845604280626881e+45M

Annual income

$3,845,513,504,141,571,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IMGI

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMGI buys

JNJ buys

No recent congressional trades found for IMGI or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMGIJNJ

Forward yield	8333333.33% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$7.691208561253763e+45M	$30.3K ✓
Annual income after 10y	$7,691,027,008,283,142,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$7.69119668371173e+45M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: IMGI vs JNJ ($10,000, DRIP)

Year	IMGI Portfolio	IMGI Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$833,344,033	$833,333,333.33	$10,592	$272.30	+$833.33M → IMGI
2	$64,903,074,959,528	$64,902,183,281,412.24	$11,289	$357.73	+$64903074.95M → IMGI
3	$4,724,141,050,762,790,000	$4,724,071,604,472,582,000.00	$12,123	$472.89	+$4724141050762.78M → IMGI
4	$321,363,913,986,806,200,000,000	$321,358,859,155,881,900,000,000.00	$13,141	$629.86	+$321363913986806208.00M → IMGI
5	$20,430,926,468,170,230,000,000,000,000	$20,430,582,608,782,265,000,000,000,000.00	$14,408	$846.81	+$2.043092646817023e+22M → IMGI
6	$1,213,935,878,245,691,600,000,000,000,000,000	$1,213,914,017,154,370,600,000,000,000,000,000.00	$16,021	$1,151.60	+$1.2139358782456916e+27M → IMGI
7	$67,409,359,968,130,150,000,000,000,000,000,000,000	$67,408,061,056,740,430,000,000,000,000,000,000,000.00	$18,122	$1,588.22	+$6.740935996813015e+31M → IMGI
8	$3,498,335,588,078,376,400,000,000,000,000,000,000,000,000	$3,498,263,460,063,210,600,000,000,000,000,000,000,000,000.00	$20,930	$2,228.20	+$3.498335588078376e+36M → IMGI
9	$169,675,673,476,204,440,000,000,000,000,000,000,000,000,000,000	$169,671,930,257,125,210,000,000,000,000,000,000,000,000,000,000.00	$24,792	$3,191.91	+$1.6967567347620445e+41M → IMGI
10	$7,691,208,561,253,762,000,000,000,000,000,000,000,000,000,000,000,000	$7,691,027,008,283,142,000,000,000,000,000,000,000,000,000,000,000,000.00	$30,274	$4,689.40	+$7.691208561253763e+45M → IMGI

IMGI vs JNJ: Complete Analysis 2026

IMGI — Stock

Imaginon, Inc., an information technology company, focuses on developing and marketing broadband and wireless Internet and Intranet software systems. The company primarily offers ImaginVideo, a client-server application for the delivery and management of interactive video over TCP/IP networks. It also provides ImaginAuthor, a Windows-based authoring tool for creating interactive Windows Media video content; and outsourcing service for the hosting of video content to a service provider running Windows 2000 Servers. The company was founded in 1996 and is based in San Carlos, California.

Full IMGI Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this IMGI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMGI vs SCHD IMGI vs JEPI IMGI vs O IMGI vs KO IMGI vs MAIN IMGI vs ABBV IMGI vs MRK IMGI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.